Table 2 Summary of HSV‐2 reactivation and shedding estimates for the cohort of 18 women obtained using the model of HSV‐2 within‐host dynamics.

Quantity	Median (range) of 18 point estimates
	Baseline	Follow‐up
Mucosal shedding episodes/year	16 (8–48)	12 (6–43)
Duration of mucosal shedding episodes, days	1.7 (1.2–39)	2.1(1.4–11)
Reactivations/year	21 (8–234)	13 (7–94)
Duration of reactivations, days	1.6 (1.1–5.1)	2.0 (1.3–5.2)
Percentage of reactivations occurring during shedding episodes	10% (0–96%)	7% (0–73%)